Results 121 to 130 of about 5,308,235 (232)

Interleukin‐12: Central Roles in Immune Regulation and Disease Therapy

open access: yesImmunology &Cell Biology, Volume 104, Issue 10, Page 996-1014, November‐December 2026.
IL‐12 levels are tightly regulated to balance effective protective immunity against infections and cancer with the risk of excessive inflammation and autoimmune disease. Both insufficient and excessive IL‐12 activity can therefore be detrimental, highlighting the importance of precisely controlling its production and signaling. ABSTRACT Interleukin‐12 (
Anthi Psoma, Geert van den Bogaart
wiley   +1 more source

Key Barriers and Solutions to Implementing Prompt and Concurrent HAART and Anti- Tuberculosis Therapy Identified by Bugando Medical Centre Staff Members in Mwanza, Tanzania.

open access: yes, 2014
Key: ART: antiretroviral therapy. HAART: highly active anti-retroviral therapy. PEP: post-exposure prophylaxis. TB: tuberculosis.
Jennifer A. Downs (338102)   +5 more
core   +1 more source

Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia

open access: yesScientific Reports
Nearly half of the deaths among hospitalized human immuno deficiency virus-infected patients in the highly active antiretroviral therapy era have been attributed to liver disease.
Tefera Darge   +4 more
doaj   +1 more source

A MUC13 Variant Enhances Intestinal Ferric Iron Absorption in Unexplained Hyperferritinemia

open access: yesLiver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background & Aims Hyperferritinemia frequently remains unexplained despite comprehensive evaluation. We conducted a sequencing‐based exome association study to identify genetic variants associated with plasma ferritin levels in patients with unexplained hyperferritinemia.
Jonas Callet   +22 more
wiley   +1 more source

Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy-1

open access: yes, 2011
Copyright information:Taken from "Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy"BMC Infectious Diseases 2004;4():46-46.Published online 6 Nov 2004PMCID:PMC533877.Copyright © 2004
Enrica Tamburrini (57176)   +7 more
core   +1 more source

Care of patients on anti-retroviral therapy in kumasi metropolis.

open access: yesGhana medical journal, 2011
To assess the characteristics of a cross-section of HIV infected persons receiving treatment from the Antiretroviral Therapy (ART) clinic in Komfo Anokye Teaching Hospital (KATH), Kumasi and highlight perspectives related to taking their treatment.Using a structured questionnaire, sociodemographic characteristics and information related to taking ART ...
S, Ohene, E, Forson
openaire   +1 more source

Anemia and associated factors among adult people living with HIV/AIDS receiving anti-retroviral therapy at Gedeo Zone, SNNPR, Ethiopia, 2018

open access: yes, 2019
Anemia and associated factors among adult people living with HIV/AIDS receiving anti-retroviral therapy at Gedeo Zone, SNNPR, Ethiopia ...
WA Zenebe (20349132)   +2 more
core  

Drug induced liver injury in patients on anti-tubercular therapy and/or anti-retroviral therapy at Helen Joseph hospital, Johannesburg, South Africa [PDF]

open access: yes, 2019
A research report submitted to the Faculty of Health Sciences, University of Witwatersrand, Johannesburg, in partial fulfilment of the requirements for the degree of Master in Internal Medicine.
Mehta, Ruchika
core  

ANTI RETROVIRAL THERAPY ASSOCIATED MASTOPATHY

open access: yesAustralasian Medical Journal, 2012
Smite Balwant Sankaye   +1 more
openaire   +1 more source

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.

open access: yes, 2000
Treatment of HIV-1-infected individuals with a combination of anti-retroviral agents results in sustained suppression of HIV-1 replication, as evidenced by a reduction in plasma viral RNA to levels below the limit of detection of available assays ...
Nelson, M   +21 more
core  

Home - About - Disclaimer - Privacy